SIRIO Pharma, a global CDMO, has invested €16 million in a dedicated and purpose-built packaging facility, with automated packaging lines, at its Pritzwalk campus near Berlin, Germany. This brings its total investment at the site to €19 million over the last five years. 
 
The new facility features state-of-the-art bottling and blistering lines, supporting both bulk supply and private label options. This enables SIRIO to offer customers services from formulation development to final product packaging.
 
The facility is designed to ensure the seamless transfer of pharmaceutical and nutraceutical softgels from the adjacent manufacturing site, all operating under a unified pharmaceutical GMP standards regimen, approved for both human and veterinary medicinal products. 
 
The new packaging lines are equipped with advanced process-control technologies, including a fully automated bottling line with robotic palletization. Operating to pharmaceutical-grade GMP standards, these packaging lines support rapid processing, with production-to-delivery times as fast as three weeks.
 
The facility’s two new lines include a high-speed bottling line with a customizable output of up to 5 million bottles per year, accommodating bottle sizes ranging from 75ml to 400ml. The second line can fill 20 million blister packs annually, across ten blister formats, tailored for both oval and oblong softgels. The site has an overall bulk production capacity of 2 billion capsules per year.
 
To guarantee stringent quality control, the packaging lines are fitted with advanced visual inspection systems and in-line process control technologies that monitor parameters such as physical appearance, product weight, and metal detection—so sensitive that even a single capsule failure triggers an operator alert, according to the company.
 
“We have grown significantly in recent years and, as a result, have doubled down on investing in advanced manufacturing technology. With our state-of-the-art packaging facility, we now offer full-service, pharmaceutical-grade softgel development in Germany. Our teams bring incredible experience, spanning over 30 years, and by completing everything from R&D to final packaging on a single site, we offer significant advantages to our customers, who benefit from pharma-grade quality at every phase of production,” said Sara Lesina, General Manager, SIRIO Europe & Americas.